We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Kraig Biocraft Laboratories Inc (QB) | USOTC:KBLB | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.00225 | -2.39% | 0.09175 | 0.0915 | 0.0939 | 0.0955 | 0.09175 | 0.09525 | 200,111 | 21:00:40 |
|
SEC File Number 333-192272
|
|
CUSIP Number 04521X109
|
(Check
One):
|
[ ]
Form 10-K [ ] Form
11-K
[ ]
Form 20-F [X] Form
10-Q
|
|
[ ]
Form 10-D [ ] Form
N-SAR [ ] Form
N-CSR
|
|
For
Period Ended: September 30, 2017
|
|
|
|
[ ]
Transition Report on Form 10-K
|
|
|
|
[ ]
Transition Report on Form 20-F
|
|
|
|
[ ]
Transition Report on Form 11-K
|
|
|
|
[ ]
Transition Report on Form 10-Q
|
|
|
|
[ ]
Transition Report on Form N-SAR
|
|
|
|
For
Transition Period
Ended:_________________________________________________
|
|
(a)
|
The
reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or
expense;
|
|
|
|
[X]
|
(b)
|
The
subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be
filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report or transition
report on Form 10-Q or portion thereof will be filed on or before
the fifth calendar day following the prescribed due date;
and
|
|
|
|
|
(c)
|
The
accountant’s statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
Kim
Thompson
|
|
734
|
|
619-8066
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such
shorter period that the registrant was required to file such
report(s) been filed? If the answer is no, identify
report(s).
|
|
|
|
[X] Yes
[ ] No
|
(3)
|
Is it
anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof?
|
|
|
|
[ ]
Yes [X] No
|
|
|
Date: November
15, 2017
|
By:
|
/ s / Kim
Thompson
|
|
|
Kim
Thompson
|
|
|
President,
Chief Executive Officer and Chief Financial Officer (Principal
Executive Officer and Principal Financial and Accounting
Officer)
|
1 Year Kraig Biocraft Laborator... (QB) Chart |
1 Month Kraig Biocraft Laborator... (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions